Muñoz E - Search Results

1

Bryostatin-1 for latent virus reactivation in HIV-infected patients on antiretroviral therapy.

Gutiérrez C, Serrano-Villar S, Madrid-Elena N, Pérez-Elías MJ, Martín ME, Barbas C, Ruipérez J, Muñoz E, Muñoz-Fernández MA, Castor T, Moreno S. Gutiérrez C, et al. Among authors: munoz e, munoz fernandez ma. AIDS. 2016 Jun 1;30(9):1385-92. doi: 10.1097/QAD.0000000000001064. AIDS. 2016. PMID: 26891037 Clinical Trial.

2

Differential effects of phorbol-13-monoesters on human immunodeficiency virus reactivation.

Márquez N, Calzado MA, Sánchez-Duffhues G, Pérez M, Minassi A, Pagani A, Appendino G, Diaz L, Muñoz-Fernández MA, Muñoz E. Márquez N, et al. Among authors: munoz e, munoz fernandez ma. Biochem Pharmacol. 2008 Mar 15;75(6):1370-80. doi: 10.1016/j.bcp.2007.12.004. Epub 2007 Dec 23. Biochem Pharmacol. 2008. PMID: 18241838

3

Bryostatin-1 synergizes with histone deacetylase inhibitors to reactivate HIV-1 from latency.

Pérez M, de Vinuesa AG, Sanchez-Duffhues G, Marquez N, Bellido ML, Muñoz-Fernandez MA, Moreno S, Castor TP, Calzado MA, Muñoz E. Pérez M, et al. Among authors: munoz e, munoz fernandez ma. Curr HIV Res. 2010 Sep;8(6):418-29. doi: 10.2174/157016210793499312. Curr HIV Res. 2010. PMID: 20636281

4

Activation of latent HIV-1 expression by protein kinase C agonists. A novel therapeutic approach to eradicate HIV-1 reservoirs.

Sánchez-Duffhues G, Vo MQ, Pérez M, Calzado MA, Moreno S, Appendino G, Muñoz E. Sánchez-Duffhues G, et al. Among authors: munoz e. Curr Drug Targets. 2011 Mar 1;12(3):348-56. doi: 10.2174/138945011794815266. Curr Drug Targets. 2011. PMID: 20955147 Review.

5

Intensification of antiretroviral therapy with a CCR5 antagonist in patients with chronic HIV-1 infection: effect on T cells latently infected.

Gutiérrez C, Díaz L, Vallejo A, Hernández-Novoa B, Abad M, Madrid N, Dahl V, Rubio R, Moreno AM, Dronda F, Casado JL, Navas E, Pérez-Elías MJ, Zamora J, Palmer S, Muñoz E, Muñoz-Fernández MÁ, Moreno S. Gutiérrez C, et al. Among authors: munoz e, munoz fernandez ma. PLoS One. 2011;6(12):e27864. doi: 10.1371/journal.pone.0027864. Epub 2011 Dec 8. PLoS One. 2011. PMID: 22174752 Free PMC article. Clinical Trial.

6

The effect of intensification with raltegravir on the HIV-1 reservoir of latently infected memory CD4 T cells in suppressed patients.

Vallejo A, Gutierrez C, Hernandez-Novoa B, Diaz L, Madrid N, Abad-Fernandez M, Dronda F, Perez-Elias MJ, Zamora J, Muñoz E, Muñoz-Fernandez MA, Moreno S. Vallejo A, et al. Among authors: munoz e, munoz fernandez ma. AIDS. 2012 Sep 24;26(15):1885-94. doi: 10.1097/QAD.0b013e3283584521. AIDS. 2012. PMID: 22992577 Clinical Trial.

7

Bryostatin activates HIV-1 latent expression in human astrocytes through a PKC and NF-ĸB-dependent mechanism.

Díaz L, Martínez-Bonet M, Sánchez J, Fernández-Pineda A, Jiménez JL, Muñoz E, Moreno S, Álvarez S, Muñoz-Fernández MÁ. Díaz L, et al. Among authors: munoz e, munoz fernandez ma. Sci Rep. 2015 Jul 22;5:12442. doi: 10.1038/srep12442. Sci Rep. 2015. PMID: 26199173 Free PMC article.

8

Antiretroviral drugs do not interfere with bryostatin-mediated HIV-1 latency reversal.

Martínez-Bonet M, Clemente MI, Álvarez S, Díaz L, García-Alonso D, Muñoz E, Moreno S, Muñoz-Fernández MÁ. Martínez-Bonet M, et al. Among authors: munoz e, munoz fernandez ma. Antiviral Res. 2015 Nov;123:163-71. doi: 10.1016/j.antiviral.2015.09.014. Epub 2015 Sep 30. Antiviral Res. 2015. PMID: 26427554

9

Synergistic Activation of Latent HIV-1 Expression by Novel Histone Deacetylase Inhibitors and Bryostatin-1.

Martínez-Bonet M, Clemente MI, Serramía MJ, Muñoz E, Moreno S, Muñoz-Fernández MÁ. Martínez-Bonet M, et al. Among authors: munoz e, munoz fernandez ma. Sci Rep. 2015 Nov 13;5:16445. doi: 10.1038/srep16445. Sci Rep. 2015. PMID: 26563568 Free PMC article.

10

Polyanionic carbosilane dendrimers as a new adjuvant in combination with latency reversal agents for HIV treatment.

Relaño-Rodríguez I, Juárez-Sánchez R, Pavicic C, Muñoz E, Muñoz-Fernández MÁ. Relaño-Rodríguez I, et al. Among authors: munoz e, munoz fernandez ma. J Nanobiotechnology. 2019 May 21;17(1):69. doi: 10.1186/s12951-019-0500-4. J Nanobiotechnology. 2019. PMID: 31113488 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,400 results

Search Page

Filters